Abscopal effect in a patient with malignant pleural mesothelioma treated with palliative radiotherapy and pembrolizumab

Hegde, 2020, Top 10 challenges in cancer immunotherapy, Immunity, 52, 17, 10.1016/j.immuni.2019.12.011 Scherpereel, 2018, Novel therapies for malignant pleural mesothelioma, Lancet Oncol, 19, e161, 10.1016/S1470-2045(18)30100-1 Herrera, 2017, Radiotherapy combination opportunities leveraging immunity for the next oncology practice: radiation-immunotherapy combinations, CA Cancer J Clin, 67, 65, 10.3322/caac.21358 Reynders, 2015, The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant, Cancer Treat Rev., 41(6), 503, 10.1016/j.ctrv.2015.03.011 Alley, 2017, Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial, Lancet Oncol, 18, 623, 10.1016/S1470-2045(17)30169-9 Popat, 2019, A multicentre randomized phase III trial comparing pembrolizumab (P) vs single agent chemotherapy (CT) for advanced pre-treated malignant pleural mesothelioma (MPM): results from the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial, Ann Oncol, 30, v851, 10.1093/annonc/mdz394.091 Postow, 2012, Immunologic correlates of the abscopal effect in a patient with melanoma, N Engl J Med, 366, 925, 10.1056/NEJMoa1112824 Demaria, 2004, Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated, Int J Radiat Oncol Biol Phys, 58, 862, 10.1016/j.ijrobp.2003.09.012 Weichselbaum, 2017, Radiotherapy and immunotherapy: a beneficial liaison?, Nat Rev Clin Oncol, 14, 365, 10.1038/nrclinonc.2016.211 Dovedi, 2014, Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade, Cancer Res, 74, 5458, 10.1158/0008-5472.CAN-14-1258 Dewan, 2009, Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti–CTLA-4 antibody, Clin Cancer Res, 15, 5379, 10.1158/1078-0432.CCR-09-0265 Vanpouille-Box, 2017, DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity, Nat Commun, 8, 15618, 10.1038/ncomms15618 Ko, 2018, Generating antitumor immunity by targeted radiation therapy: role of dose and fractionation, Adv Radiat Oncol, 3, 486, 10.1016/j.adro.2018.08.021